A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Current in vitro and animal tests for drug development are failing to emulate the systemic organ complexity of the human body and, therefore, to accurately predict drug toxicity. In this study, we present a multi-organ-chip capable of maintaining 3D tissues derived from cell lines, primary cells and biopsies of various human organs. We designed a multi-organ-chip with co-cultures of human artificial liver microtissues and skin biopsies, each a (1)/100,000 of the biomass of their original human organ counterparts, and have successfully proven its long-term performance. The system supports two different culture modes: i) tissue exposed to the fluid flow, or ii) tissue shielded from the underlying fluid flow by standard Transwell® cultures. Crosstalk between the two tissues was observed in 14-day co-cultures exposed to fluid flow. Applying the same culture mode, liver microtissues showed sensitivity at different molecular levels to the toxic substance troglitazone during a 6-day exposure. Finally, an astonishingly stable long-term performance of the Transwell®-based co-cultures could be observed over a 28-day period. This mode facilitates exposure of skin at the air-liquid interface. Thus, we provide here a potential new tool for systemic substance testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“More recently, developers are increasingly starting to produce their chips from thermoplastic materials, already used in other biotechnological applications: polystyrene (Lee et al., 2018), poly(methyl methacrylate) (Busek et al., 2021), polycarbonate (Wagner et al., 2013), and cyclic olefin copolymer. While being amenable for cheaper and more scalable fabrication processes as well as providing”
From Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility (2024) · cites this paper as Wagner et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The metabolic activity and function of cells fluctuate over time and similar observations have been reported in the literature [61,62].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,372
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
From 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Perfused multiwell plate for 3D liver tissue engineering
Domansky, K., Inman, W., Serdy, J., Dash, A., Lim, M. H. M., & Griffith, L. G. (2010) · Lab Chip · doi:10.1039/b913221j · Cited by 444
Zhang, C., Zhao, Z., Abdul Rahim, N. A., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b915147h · Cited by 340
Sung, J. H., Esch, M. B., Prot, J.-M., Long, C. J., Smith, A., Hickman, J. J., & Shuler, M. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41017j · Cited by 233
Lübberstedt, M., Müller-Vieira, U., Mayer, M., Biemel, K. M., Knöspel, F., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Zeilinger, K. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.04.013 · Cited by 227
Marx, U., Walles, H., Hoffmann, S., Lindner, G., Horland, R., Sonntag, F., Klotzbach, U., Sakharov, D., Tonevitsky, A., & Lauster, R. (2012) · Alternatives to Laboratory Animals · doi:10.1177/026119291204000504 · Cited by 177
Self-citationImura, Y., Sato, K., & Yoshimura, E. (2010) · Analytical Chemistry · doi:10.1021/ac100806x · Cited by 172
Research works printed but not linked: 1
- Ramachandran, 1999, Drug Metab. Dispos., 27, 1194
Cited by
Items 201–300 of 476
Real-time physiological sensor-based liver-on-chip device for monitoring drug toxicity
Farooqi, H. M. U., Khalid, M. A. U., Kim, K. H., Lee, S. R., & Choi, K. H. (2020) · Journal of Micromechanics and Microengineering · doi:10.1088/1361-6439/ababf4 · Cited by 48
Coenzyme Q10 Efficacy Test for Human Skin Equivalents Using a Pumpless Skin-On-A-Chip System
Kim, J., Kim, K., & Sung, G. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228475 · Cited by 45
“[10] While in vitro 2D skin models are physiologically relevant, because real human skin tissue comprises various cell types, including keratinocytes, fibroblasts, vascular cells, and immune cells that can only be cultured in a 3D tissue environment, 2D models are insufficient.”
BackgroundHuman liver model systems in a dish
Thompson, W. L., & Takebe, T. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12708 · Cited by 60
“, 2014), liver and skin tissue chips (Wagner et al., 2013), liver- kidney biochips (ChouchaSnouber et al.”
BackgroundMicrofluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening
Kohl, Y., Biehl, M., Spring, S., Hesler, M., Ogourtsov, V., Todorovic, M., Owen, J., Elje, E., Kopecka, K., Moriones, O. H., et al. (2021) · Small · doi:10.1002/smll.202006012 · Cited by 44
Microfluidic based human-on-a-chip: A revolutionary technology in scientific research
Syama, S., & Mohanan, P. V. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.02.049 · Cited by 49
Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS)
Malik, M., Yang, Y., Fathi, P., Mahler, G. J., & Esch, M. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721338 · Cited by 43
“Wagner et al. (2013) exposed a liver-skin MPS to troglitazone drug repeatedly at 12 h intervals for 7 days to test the system for repeated dose substance exposure.”
Methodvan Berlo, D., van de Steeg, E., Amirabadi, H. E., & Masereeuw, R. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.05.001 · Cited by 50
Engineering living systems on chips: from cells to human on chips
Sei, Y. J., Justus, K., LeDuc, P. R., & Kim, Y. (2014) · Microfluidics and Nanofluidics · doi:10.1007/s10404-014-1341-y · Cited by 44
“While heterogeneous cocultures of eukaryotic cells have been demonstrated (Esch et al. 2012; Kusunose et al. 2013; Wagner et al. 2013), the co-culture of eukaryotic and prokaryotic cells poses challenges due to dominant prokaryotic cell growth rates compared to those of eukaryotic cells.”
BackgroundInfluentialMicrotechnology-Based Multi-Organ Models
Lee, S., & Sung, J. (2017) · Bioengineering · doi:10.3390/bioengineering4020046 · Cited by 42
“Marx and coworkers [45] applied their MOC system for the co-culture of liver and skin biopsies.”
BackgroundBioinspired Universal Flexible Elastomer‐Based Microchannels
Wu, F., Chen, S., Chen, B., Wang, M., Min, L., Alvarenga, J., Ju, J., Khademhosseini, A., Yao, Y., Zhang, Y. S., et al. (2018) · Small · doi:10.1002/smll.201702170 · Cited by 42
Lee, S. H., & Jun, B. (2018) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2018.11.041 · Cited by 46
In situ mRNA isolation from a microfluidic single-cell array using an external AFM nanoprobe
Li, X., Tao, Y., Lee, D., Wickramasinghe, H. K., & Lee, A. P. (2017) · Lab on a Chip · doi:10.1039/c7lc00133a · Cited by 44
Progress on Reconstructed Human Skin Models for Allergy Research and Identifying Contact Sensitizers
Neves, C. T. R., & Gibbs, S. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_88 · Cited by 50
In vitro and in silico liver models: Current trends, challenges and opportunities
Poloznikov, A. A., Gazaryan, I., Shkurnikov, M., Nikulin, S., Drapkina, O., Baranova, A., & Tonevitsky, A. (2018) · ALTEX · doi:10.14573/altex.1803221 · Cited by 43
“One of the most promising approaches to overcome the issues with viability of hepatocyte monoculture is the utilization of microfluidic perfusion devices (Knöspel et al., 2016; Shulman and Nahmias, 2013; Tehranirokh et al., 2013; Wagner et al., 2013).”
BackgroundBrandauer, K., Schweinitzer, S., Lorenz, A., Krauß, J., Schobesberger, S., Frauenlob, M., & Ertl, P. (2025) · Lab on a Chip · doi:10.1039/d4lc01011f · Cited by 46
Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation
Zommiti, M., Connil, N., Tahrioui, A., Groboillot, A., Barbey, C., Konto‐Ghiorghi, Y., Lesouhaitier, O., Chevalier, S., & Feuilloley, M. G. J. (2022) · Bioengineering · doi:10.3390/bioengineering9110646 · Cited by 47
Carvalho, V. M., Bañobre‐López, M., Minas, G. M. H., Teixeira, S., Lima, R. A., & Rodrigues, R. O. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00224 · Cited by 44
Academic User View: Organ-on-a-Chip Technology
Busek, M., Aizenshtadt, A., Amirola-Martinez, M., Delon, L., & Krauss, S. (2022) · Biosensors · doi:10.3390/bios12020126 · Cited by 37
“For drug screening, for instance, organ interactions are often important; therefore, most commercial platforms focus especially on this aspect either by implementing media recirculation to different organ compartments [31] or by using pipetting robots to couple single organ models with each other [32].”
BackgroundSelf-citationDifferentiation of the human liver progenitor cell line (HepaRG) on a microfluidic‐based biochip
Jang, M., Kleber, A., Ruckelshausen, T., Betzholz, R., & Manz, A. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2802 · Cited by 37
Kim, K., Kim, J., Kim, H., & Sung, G. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042160 · Cited by 41
“Previous SOC culture systems exhibited the disadvantage of complicated device configuration, which required additional pumps to generate fluid flow [29,30] and additional tubing for that purpose.”
BackgroundShanmugam, D. K., Anitha, S., Souresh, V., Madhavan, Y., Sampath, S., Venugopal, D. C., & Saravanan, M. (2023) · Materials Technology · doi:10.1080/10667857.2023.2242732 · Cited by 46
“It is a microfluidic chip that simulates breathing, highly resistant lungs made of human passages, vasculature, and inflammatory responses [26].”
BackgroundOrgans-on-a-chip: A new paradigm for toxicological assessment and preclinical drug development
Bovard, D., Iskandar, A., Luettich, K., Hoeng, J., & Peitsch, M. C. (2017) · Toxicology Research and Application · doi:10.1177/2397847317726351 · Cited by 35
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
Gündel, B., Liu, X., Löhr, M. J., & Heuchel, R. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741162 · Cited by 47
“A relatively new application is investigating multi-organ crosstalk (Wagner et al., 2013; Schimek et al., 2020).”
BackgroundBeiβner, N., Mattern, K., Dietzel, A. H., & Reichl, S. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.021 · Cited by 44
“One tremendous innovation in this field was the development of organ on chip (OOC) systems in the early 2010s [3,22,55].”
BackgroundAn on-chip intestine-liver model for multiple drugs absorption and metabolism behavior simulation
Jie, M., Lin, H., He, Z., Liu, H., Li, H., & Lin, J. (2017) · Science China Chemistry · doi:10.1007/s11426-017-9167-0 · Cited by 34
Alternatives to animal testing in basic and preclinical research of atopic dermatitis
Löwa, A., Jevtić, M., Gorreja, F., & Hedtrich, S. (2018) · Experimental Dermatology · doi:10.1111/exd.13498 · Cited by 45
Microengineered Organ-on-a-chip Platforms towards Personalized Medicine
Kankala, R. K., Wang, S., & Chen, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190222143542 · Cited by 40
Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives
Çeçen, B., Karavasili, C., Nazir, M., Bhusal, A., Dogan, E., Shahriyari, F., Tamburacı, S., Büyüköz, M., Kozacı, L. D., & Miri, A. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101657 · Cited by 42
“Results indicated a dose-dependent response to troglitazone after the 6-day treatment [38].”
BackgroundLiver-on-a-chip: Considerations, advances, and beyond
Yang, Z., Liu, X., Cribbin, E. M., Kim, A. M., Li, J. J., & Yong, K. (2022) · Biomicrofluidics · doi:10.1063/5.0106855 · Cited by 36
Skin-on-a-chip technologies towards clinical translation and commercialization
Ismayilzada, N., Tarar, C., Dabbagh, S. R., Tokyay, B. K., Dilmani, S. A., Sokullu, E., Abaci, H. E., & Taşoğlu, S. (2024) · Biofabrication · doi:10.1088/1758-5090/ad5f55 · Cited by 43
“These in vitro skin models are well suited for drug screening and toxicity studies [45–47].”
Bioreactors for Mammalian Cells
Pörtner, R. (2014) · Cell engineering · doi:10.1007/978-3-319-10320-4_4 · Cited by 42
“heart, lung, kidney, artery, bone, cartilage, skin and more, either as single organ or several organs combined (Park and Shuler 2003; Huh et al. 2012, 2013; Wagner et al. 2013).”
BackgroundDrug delivery for traditional and emerging airway models
Karra, N., Swindle, E. J., & Morgan, H. (2019) · Organs-on-a-Chip · doi:10.1016/j.ooc.2020.100002 · Cited by 37
Tavares, R. S. N., Tao, T. P., Maschmeyer, I., Maria–Engler, S. S., Schäfer‐Korting, M., Winter, A., Zoschke, C., Lauster, R., Marx, U., & Gaspar, L. R. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119788 · Cited by 38
Self-citationTao, T. P., Brandmair, K., Gerlach, S., Przibilla, J., Géniès, C., Jacques, C., Schepky, A. G., Marx, U., Hewitt, N. J., Maschmeyer, I., et al. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4146 · Cited by 33
“HUMIMIC Chips are the only MPS currently available that include a compartment for a 3D skin model (Atac et al., 2013; Kühnl et al., 2021; Wagner et al., 2013).”
MethodSelf-citationKulsharova, G., Kurmangaliyeva, A., Darbayeva, E., Rojas–Solórzano, L., & Toxeitova, G. (2021) · Polymers · doi:10.3390/polym13193215 · Cited by 35
“It is reported in the literature that the function and activity of cells can fluctuate over time [39,45].”
BackgroundDiffusion phenomena of cells and biomolecules in microfluidic devices
Yıldız-Ozturk, E., & Yeşil-Çeliktaş, Ö. (2015) · Biomicrofluidics · doi:10.1063/1.4923263 · Cited by 33
Wartmann, D., Rothbauer, M., Kuten, O., Barresi, C., Visús, C., Felzmann, T., & Ertl, P. (2015) · Frontiers in Materials · doi:10.3389/fmats.2015.00060 · Cited by 34
“From that point on the development of highly complex cell-chip devices that incorporate micropumps and valves, mixers, actuators, degassers, biosensors, as well as multiple cell cultivation chambers for multiplexed cell analysis, adapting the concept of μTAS and labs-on-achip for cell-based applications has continuous…”
BackgroundThe Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
Materne, E.-M., Maschmeyer, I., Lorenz, A., Horland, R., Schimek, K. M. S., Busek, M., Sonntag, F., Lauster, R., & Marx, U. (2015) · Journal of Visualized Experiments · doi:10.3791/52526-v · Cited by 32
Self-citationRecapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models
Kim, J., & Tanner, K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00170 · Cited by 31
Mimicking the Human Physiology with Microphysiological Systems (MPS)
Sung, J. H., Koo, J., & Shuler, M. L. (2019) · BioChip Journal · doi:10.1007/s13206-019-3201-z · Cited by 33
Microfluidic Cell Trapping for Single-Cell Analysis
Deng, B., Wang, H., Tan, Z., & Quan, Y. (2019) · Micromachines · doi:10.3390/mi10060409 · Cited by 30
“screening and separation of different types of cells [12] and even building tissue and organ models on a chip [13].”
BackgroundTissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing
Donoghue, L., Nguyen, K. T. V., Graham, C., & Sethu, P. (2021) · Micromachines · doi:10.3390/mi12020139 · Cited by 34
“[155] Liver–Skin Drug Testing 2013 Vunjak-Novakovic et al.”
Hydrogel-Based Strategies for Liver Tissue Engineering
Zhang, Y., Li, L., Dong, L., Cheng, Y., Huang, X., Xue, B., Jiang, C., Cao, Y., & Yang, J. (2024) · Chem & Bio Engineering · doi:10.1021/cbe.4c00079 · Cited by 39
Pagnotta, G., Kalia, S., Lisa, L. D., Cicero, A. F. G., Borghi, C., & Focarete, M. L. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00218 · Cited by 34
Cook, S. R., Ball, A. G., Mohammad, A., & Pompano, R. R. (2024) · Lab on a Chip · doi:10.1039/d4lc00489b · Cited by 34
Beißner, N., Lorenz, T., & Reichl, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-26920-7_11 · Cited by 38
Circadian hormone control in a human-on-a-chip: In vitro biology’s ignored component?
Cyr, K. J., Avaldi, O. M., & Wikswo, J. P. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217732766 · Cited by 30
Leaf-templated, microwell-integrated microfluidic chips for high-throughput cell experiments
Mao, M., He, J., Lu, Y., Li, X., Li, T., Zhou, W., & Li, D. (2018) · Biofabrication · doi:10.1088/1758-5090/aaa900 · Cited by 32
Raasch, M., Fritsche, E., Kurtz, A., Bauer, M., & Mosig, A. S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.008 · Cited by 29
Engineering a Blood Vessel Network Module for Body-on-a-Chip Applications
Ryu, H., Oh, S., Lee, H. J., Lee, J. Y., Lee, H., & Jeon, N. L. (2014) · SLAS TECHNOLOGY · doi:10.1177/2211068214562831 · Cited by 37
“Furthermore, the body-on-a-chip platform has been proposed as a toxicological assay.(6) Blood vessels, the most important conduit for organs, were recently engineered on a microfluidic platform.”
BackgroundBal‐Öztürk, A., Miccoli, B., Avci‐Adali, M., Mogtader, F., Sharifi, F., Çeçen, B., Yaşayan, G., Braeken, D., & Alarçın, E. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190206195304 · Cited by 30
Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 34
Kim, J., Lee, H., Selimović, Š., Gauvin, R., & Bae, H. (2015) · Drug Safety · doi:10.1007/s40264-015-0284-x · Cited by 34
In Vitro Intestinal and Liver Models for Toxicity Testing
Orbach, S. M., Less, R. R., Kothari, A., & Rajagopalan, P. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00699 · Cited by 31
Multi-organ on a chip for personalized precision medicine
Palaninathan, V., Kumar, V., Maekawa, T., Liepmann, D., Paulmurugan, R., Eswara, J. R., Ajayan, P. M., Augustine, S., Malhotra, B. D., Viswanathan, S., et al. (2018) · MRS Communications · doi:10.1557/mrc.2018.148 · Cited by 29
Park, S. M., Eom, S., Hong, H., Yoon, J., Lee, S. J., Kim, B. C., Kim, H. W., & Kim, D. S. (2018) · Microelectronic Engineering · doi:10.1016/j.mee.2018.10.010 · Cited by 31
Maaß, C., Dallas, M. R., LaBarge, M. E., Shockley, M., Valdez, J., Geishecker, E., Stokes, C. L., Griffith, L. G., & Cirit, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25971-y · Cited by 26
Evaluating nanomedicine with microfluidics
He, Z., Ranganathan, N., & Li, P. (2018) · Nanotechnology · doi:10.1088/1361-6528/aae18a · Cited by 27
Vahav, I., Thon, M., van den Broek, L. J., Spiekstra, S. W., Ataç, B., Lindner, G., Schimek, K. M. S., Marx, U., & Gibbs, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081529 · Cited by 26
Self-citationMiddelkamp, H. H. T., van der Meer, A. D., Hummel, J. M., Stamatialis, D. F., Mummery, C. L., Passier, R. C., & IJzerman, M. J. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0029 · Cited by 27
Zambon, A., Zoso, A., Gagliano, O., Magrofuoco, E., Fadini, G. P., Avogaro, A., D, M. F. M., Quake, S. R., & Elvassore, N. (2015) · Analytical Chemistry · doi:10.1021/ac504730r · Cited by 25
Membrane-based microfluidic systems for medical and biological applications
Calzuola, S. T., Newman, G., Feaugas, T., Perrault, C. M., Blondé, J.-B., Roy, E., Porrini, C., Stojanović, G. M., & Vidić, J. (2024) · Lab on a Chip · doi:10.1039/d4lc00251b · Cited by 24
Kim, J. J., Bae, M., & Cho, D. (2024) · Small Science · doi:10.1002/smsc.202400314 · Cited by 29
Microphysiological systems for the modeling of wound healing and evaluation of pro-healing therapies
Deal, H. E., Brown, A. C., & Daniele, M. A.-A. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00544d · Cited by 26
Zhao, P., Wang, J., Chen, C., Wang, J., Liu, G., Nandakumar, K., Li, Y., & Wang, L. (2022) · Micromachines · doi:10.3390/mi13020200 · Cited by 27
Microtechnology‐based organ systems and whole‐body models for drug screening
Lee, S. H., Ha, S. K., Choi, I., Choi, N., Park, T. H., & Sung, J. H. (2016) · Biotechnology Journal · doi:10.1002/biot.201500551 · Cited by 25
“The Marx group designed a MOC for co-culture of artificial liver microtissues and skin biopsies [79].”
MethodThe Use of Microfluidics in Cytotoxicity and Nanotoxicity Experiments
McCormick, S., Kriel, F. H., Ivask, A., Tong, Z., Lombi, E., Voelcker, N. H., & Priest, C. (2017) · Micromachines · doi:10.3390/mi8040124 · Cited by 29
“[49] utilized this beneficial technology by producing a microfluidic environment with multiple culture locations, connected by the flow pathway; in which they cultured both biopsied skin tissue and pre-grown liver microtissue aggregates.”
BackgroundKurth, F., Györvary, E., Heub, S., Ledroit, D., Paoletti, S., Renggli, K., Revol, V., Verhulsel, M., Weder, G., & Loizeau, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00003-6 · Cited by 31
The value of organs-on-chip for regulatory safety assessment
Heringa, M. B., Park, M. V. D. Z., Kienhuis, A. S., & Vandebriel, R. J. (2019) · ALTEX · doi:10.14573/altex.1910111 · Cited by 28
“…lung, skin, liver, kidney, heart and intestine are already available (e.g., Grosberg et al., 2011; Huh et al., 2010; Kim and Ingber, 2013; O’Neill et al., 2008; Vedula et al., 2017), even combined in multi-organ chips (e.g., Maschmeyer et al., 2015; Oleaga et al., 2016; Wagner et al., 2013) (Tab.”
BackgroundInfluentialBiomimetic Full-Thickness Skin-on-a-Chip Based on a Fibroblast-Derived Matrix
Zoio, P., Lopes‐Ventura, S., & Oliva, A. (2022) · Micro · doi:10.3390/micro2010013 · Cited by 25
Use and application of organ-on-a-chip platforms in cancer research
Yu, Y., Zhou, T., & Cao, L.-L. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00790-7 · Cited by 31
“…Wagner presented a dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culturing Wagner et al. (2013) more physiological balance of cells (such as stromal, vascular and immune cells), and the existence of mechanical influences…”
BackgroundDouble-layer perfusable collagen microtube device for heterogeneous cell culture
Itai, S., Tajima, H., & Onoe, H. (2018) · Biofabrication · doi:10.1088/1758-5090/aaf09b · Cited by 25
Yu, Y., Sun, B., Ye, X., Wang, Y., Zhao, M., Song, J., Geng, X., Marx, U., Li, B., & Zhou, X. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.115016 · Cited by 25
Self-citationApplication of microfluidic chips in anticancer drug screening
Fan, X., Deng, Z.-F., Yan, Y., Vé, O., Shypko, A., Orel, V. B., Ivanova, D., Pilarsky, C. P., Tang, J. P., Chen, Z., et al. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6484 · Cited by 27
Developing 3D bioprinting for organs-on-chips
Wu, Z., Liu, R., Shao, N., & Zhao, Y. (2025) · Lab on a Chip · doi:10.1039/d4lc00769g · Cited by 24
Microfabricated Physiological Models for In Vitro Drug Screening Applications
Ugolini, G. S., Cruz‐Moreira, D., Visone, R., Redaelli, A. C. L., & Rasponi, M. (2016) · Micromachines · doi:10.3390/mi7120233 · Cited by 25
Sun, X., Zhang, Z., Zhao, W., Xu, S., Zhang, J., ZhuanSun, X.-M., Ye, J., Han, Y., Gu, Z., & Chen, Z. (2025) · Small · doi:10.1002/smll.202503384 · Cited by 35
A Tissue Engineering Approach to Metastatic Colon Cancer
Sarvestani, S. K., DeHaan, R. K., Miller, P. G., Bose, S., Shen, X., Shuler, M. L., & Huang, E. H. (2020) · iScience · doi:10.1016/j.isci.2020.101719 · Cited by 22
Morimoto, Y., Nagata, S., Matsumoto, M., Sugahara, K., Miura, S., & Takeuchi, S. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130675 · Cited by 19
Beißner, N., Albero, A. B., Füller, J., Kellner, T., Lauterboeck, L., Liang, J., Böl, M., Glasmacher, B., Müller-Goymann, C. C., & Reichl, S. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.11.014 · Cited by 21
“Other cell lines in combination with microfluidic systems have shown advantages such as a more in vivo-like phenotype or an extended life span resulting from flow [99,105,106] or continuous online analytics such as TEER measurement [107].”
BackgroundAeby, E. A., Misun, P. M., Hierlemann, A. R., & Frey, O. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800054 · Cited by 23
Lebeko, M., Khumalo, N. P., & Bayat, A. (2019) · Wound Repair and Regeneration · doi:10.1111/wrr.12705 · Cited by 22
Microfluidic analysis of heterotypic cellular interactions: A review of techniques and applications
Sakthivel, K., O’Brien, A., Kim, K., & Hoorfar, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.03.026 · Cited by 24
Watanabe, M., Salvadori, A., Marković, M., Sudo, R., & Ovsianikov, A. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101643 · Cited by 26
“Over the last decades, various three-dimensional (3D) biofabrication techniques have been utilized, such as cell spheroid [6 – 8], organoid [9, 10], microfluidic [11 – 13], and bioprinting techniques [14,15] to mimic the complexity of the hepatic lobule.”
Hepatocyte cultures: From collagen gel sandwiches to microfluidic devices with integrated biosensors
de Hoyos‐Vega, J. M., Hong, H. J., Stybayeva, G., & Revzin, A. (2021) · APL Bioengineering · doi:10.1063/5.0058798 · Cited by 22
Lacombe, J., Soldevila, M., & Zenhausern, F. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.019 · Cited by 25
Trends in organ-on-a-chip for pharmacological analysis
Xu, X., Cheung, S., Jia, X., Fan, G., Ai, Y., Zhang, Y., & Liang, Q. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117905 · Cited by 24
Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator
Kanamori, T., Sugiura, S., & Sakai, Y. (2017) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2017.11.006 · Cited by 21
“TissUse GmbH, a spin-off venture company of the Institute of Biotechnology of Technische Universit€ at Berlin, has developed a two-organ chip that is currently being validated by AstraZeneca and Beiersdorf AG [15].”
BackgroundIntegrated Microphysiological Systems: Transferable Organ Models and Recirculating Flow
Renggli, K., Rousset, N., Lohasz, C., Nguyen, O. T. P., & Hierlemann, A. R. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900018 · Cited by 22
Sharma, J. R., Lebeko, M., Kidzeru, E. B., Khumalo, N. P., & Bayat, A. (2019) · Advances in Wound Care · doi:10.1089/wound.2019.1040 · Cited by 21
“The controlled conditions provided with these models make it feasible to represent the environment of skin in terms of humidity, pH, oxygen levels, temperature, the elasticity of the skin, and existing cellular interactions.(107) Park et al.”
MethodYou-on-a-chip’ for precision medicine
Low, L. A., & Tagle, D. A. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1456333 · Cited by 18
Jastrzębska, E., Bułka, M., Rybicka, N., & Żukowski, K. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.08.022 · Cited by 18
Application of chemical reaction engineering principles to “body‐on‐a‐chip” systems
Sung, J. H., Wang, Y. I., Kim, J. H., Lee, J. M., & Shuler, M. L. (2018) · AIChE Journal · doi:10.1002/aic.16448 · Cited by 18
Biomimetic Cardiac Microsystems for Pathophysiological Studies and Drug Screens
Lee, J., Razu, M. E., Wang, X., Lacerda, C. M. R., & Kim, J. (2014) · SLAS TECHNOLOGY · doi:10.1177/2211068214560903 · Cited by 18
Rigal, S., Casas, B., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Müllers, E., Karlsson, F. H., Clausen, M., Hansson, S., Leonard, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06514-w · Cited by 24
Self-citationModels for barrier understanding in health and disease in lab-on-a-chips
Ponmozhi, J., Dhinakaran, S., Kocsis, D., Iván, K., & Erdő, F. (2023) · Tissue Barriers · doi:10.1080/21688370.2023.2221632 · Cited by 20
Development of Organs-on-Chips and Their Impact on Precision Medicine and Advanced System Simulation
Luo, Y., Li, X., Zhao, Y., Zhong, W., Xing, M. M. Q., & Lyu, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082094 · Cited by 18
Yang, Y., Gao, X., Widdicombe, B., Zhang, X., Zielinski, J., Cheng, T., Gunatilaka, A., Leung, K. K., Plaxco, K. W., Unnithan, R. R., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c06813 · Cited by 24
Sumiyama, K., Matsumoto, N., Garçon-Yoshida, J., Ukai, H., Ueda, H. R., & Tanaka, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203056 · Cited by 16
Generation of Scalable Hepatic Micro-Tissues as a Platform for Toxicological Studies
Darakhshan, S., Pour, A. B., Kowsari‐Esfahan, R., Vosough, M., Montazeri, L., Ghanian, M. H., Baharvand, H., & Piryaei, A. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00272-6 · Cited by 17
Metadata
- Authors
- Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., Lauster, R., & Marx, U.
- Affiliations
- Technische Universität Berlin (DE)
- Fraunhofer Institute for Material and Beam Technology (DE)
- BioClinicum (Russia) (RU)
- Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
- Corresponding author
- Wagner, Ilka
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 13
- Issue
- 18
- Pages
- 3538
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2087315598
- Cited by
- 476
- References
- 20
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 32 · 2023: 29 · 2022: 38 · 2021: 33 · 2020: 40 · 2019: 36 · 2018: 56 · 2017: 54 · 2016: 46 · 2015: 38 · 2014: 34 · 2013: 9
- FWCI
- 23.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- DepositOnce (submittedVersion, public-domain)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Technische Universität Berlin – Universitätsbibliothek
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- multi-organ-on-a-chip, organ-on-a-chip, skin biopsy, long-term tissue culture, drug toxicity testing, troglitazone, tissue crosstalk, transwell culture, air-liquid interface, human skin
- MeSH terms
- Troglitazone, Cell Line, Cell Survival, Chromans, Humans, Liver, RNA, Skin, Biomass, Coculture Techniques, Thiazolidinediones, Microfluidic Analytical Techniques, Tissue Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.